Metabolic Syndrome and Prostate Cancer: A Review

Abstract Androgen deprivation therapy is widely used in a number of different settings in the treatment of prostate cancer. This overview will look at the current evidence for the potential development of metabolic syndrome and cardiovascular disease as a consequence of this therapy, and highlight s...

Full description

Saved in:

Bibliographic Details
Published in:	Clinical oncology (Royal College of Radiologists (Great Britain)) Vol. 21; no. 3; pp. 183 - 191
Main Authors:	Nobes, J.P, Langley, S.E.M, Laing, R.W
Format:	Journal Article
Language:	English
Published:	England Elsevier Ltd 01-04-2009
Subjects:	Androgen Antagonists - adverse effects Androgen Antagonists - therapeutic use Androgen deprivation therapy Gonadotropin-Releasing Hormone - agonists Hematology, Oncology and Palliative Medicine Humans insulin resistance Male metabolic syndrome Metabolic Syndrome - etiology Orchiectomy - adverse effects prostate cancer Prostatic Neoplasms - metabolism Prostatic Neoplasms - therapy Radiology metabolic syndrome prostate cancer Androgen deprivation therapy insulin resistance
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Abstract Androgen deprivation therapy is widely used in a number of different settings in the treatment of prostate cancer. This overview will look at the current evidence for the potential development of metabolic syndrome and cardiovascular disease as a consequence of this therapy, and highlight strategies aimed at their prevention. The relationship between metabolic syndrome and prostate cancer development will also be examined.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-3 content type line 23 ObjectType-Review-1
ISSN:	0936-6555 1433-2981
DOI:	10.1016/j.clon.2008.11.013